Mettler-Toledo International (NYSE:MTD) Upgraded at StockNews.com

StockNews.com upgraded shares of Mettler-Toledo International (NYSE:MTD) from a hold rating to a buy rating in a research note released on Thursday morning.

MTD has been the subject of a number of other research reports. Stifel Nicolaus increased their price objective on shares of Mettler-Toledo International from $1,270.00 to $1,510.00 and gave the stock a buy rating in a research report on Monday, May 13th. Robert W. Baird lifted their price objective on shares of Mettler-Toledo International from $1,212.00 to $1,360.00 and gave the stock a neutral rating in a research report on Monday, May 13th. Citigroup lifted their price objective on shares of Mettler-Toledo International from $975.00 to $1,200.00 and gave the stock a sell rating in a research report on Monday, May 13th. The Goldman Sachs Group boosted their price target on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the company a neutral rating in a research report on Tuesday, July 9th. Finally, Jefferies Financial Group restated an underperform rating and issued a $1,250.00 price objective (up from $1,230.00) on shares of Mettler-Toledo International in a research note on Monday, June 3rd. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of Hold and a consensus target price of $1,301.25.

Mettler-Toledo International Trading Up 0.1 %

Shares of NYSE MTD opened at $1,359.21 on Thursday. Mettler-Toledo International has a 12-month low of $928.49 and a 12-month high of $1,535.86. The stock has a market cap of $29.03 billion, a PE ratio of 38.12, a P/E/G ratio of 3.65 and a beta of 1.17. The company has a 50-day moving average of $1,421.09 and a 200 day moving average of $1,303.95.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $8.89 earnings per share for the quarter, beating the consensus estimate of $7.61 by $1.28. Mettler-Toledo International had a net margin of 20.55% and a negative return on equity of 662.32%. The business had revenue of $925.95 million during the quarter, compared to analysts’ expectations of $879.72 million. During the same quarter in the prior year, the company posted $8.69 EPS. The business’s revenue for the quarter was down .3% on a year-over-year basis. On average, sell-side analysts forecast that Mettler-Toledo International will post 40.13 EPS for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $1,457.07, for a total transaction of $437,121.00. Following the transaction, the chief financial officer now directly owns 4,914 shares in the company, valued at $7,160,041.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $1,457.07, for a total transaction of $437,121.00. Following the transaction, the chief financial officer now directly owns 4,914 shares in the company, valued at $7,160,041.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Thomas P. Salice sold 1,268 shares of the company’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $1,490.18, for a total transaction of $1,889,548.24. Following the transaction, the director now owns 244 shares in the company, valued at $363,603.92. The disclosure for this sale can be found here. Over the last three months, insiders have sold 3,278 shares of company stock worth $4,871,849. 1.94% of the stock is owned by company insiders.

Institutional Trading of Mettler-Toledo International

Several institutional investors and hedge funds have recently modified their holdings of MTD. Bank of New York Mellon Corp lifted its holdings in shares of Mettler-Toledo International by 169.4% in the first quarter. Bank of New York Mellon Corp now owns 573,702 shares of the medical instruments supplier’s stock valued at $763,764,000 after purchasing an additional 360,786 shares in the last quarter. Norges Bank purchased a new stake in shares of Mettler-Toledo International in the fourth quarter valued at about $320,847,000. Capital International Investors lifted its holdings in shares of Mettler-Toledo International by 15.1% in the first quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock valued at $1,431,696,000 after purchasing an additional 141,431 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Mettler-Toledo International by 65.4% in the fourth quarter. Principal Financial Group Inc. now owns 241,219 shares of the medical instruments supplier’s stock valued at $292,589,000 after purchasing an additional 95,421 shares in the last quarter. Finally, International Assets Investment Management LLC lifted its holdings in shares of Mettler-Toledo International by 109,458.1% in the fourth quarter. International Assets Investment Management LLC now owns 67,926 shares of the medical instruments supplier’s stock valued at $82,392,000 after purchasing an additional 67,864 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.